TradingKey

关于 Neogen Corp 公司

Neogen Corporation 致力于开发、制造和营销一系列致力于食品和动物安全的产品和服务。公司通过两个部门运营：食品安全和动物安全。其食品安全部门主要包括诊断检测试剂盒和补充产品，这些产品出售给食品生产商和加工商，用于检测人类食品和动物饲料中的危险和/或非预期物质，例如食源性病原体、腐败菌、天然毒素、食品过敏原、基因改造、反刍动物副产品、肉类物种、药物残留、农药残留和一般卫生问题。公司的动物安全部门致力于为全球动物安全市场开发、制造、营销和分销兽医器械、药品、疫苗、外用药、杀虫剂、诊断产品、灭鼠产品、清洁剂、消毒剂、昆虫控制产品和基因组学检测服务。

公司简介

公司代码NEOG

公司名称Neogen Corp

上市日期Aug 23, 1989

成立日期1981

CEOMr. John Edward Adent

员工数量- -

证券类型Ordinary Share

年结日Aug 23

公司地址620 Lesher Pl

城市LANSING

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编48912

电话15173729200

网址https://www.neogen.com/

公司代码NEOG

上市日期Aug 23, 1989

成立日期1981

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. John Edward Adent

President, Chief Executive Officer, Director

271.28K

+0.78%

Mr. David Hartman Naemura

Chief Financial Officer, Chief Operating Officer

124.19K

+73.77%

Mr. James C. (Jim) Borel

Independent Chairman of the Board

90.47K

+255.16%

Dr. Amy M. Rocklin, Ph.D.

Chief Legal & Compliance Officer

80.44K

+118.27%

Dr. William T. (Bill) Boehm, Ph.D.

Independent Director

35.59K

+16.34%

Ms. Aashima Gupta

Independent Director

27.99K

+133.42%

Dr. Catherine E. Woteki, Ph.D.

Independent Director

13.24K

+77.20%

Dr. Ronald D. Green, Ph.D.

Independent Director

12.78K

+46.92%

Ms. Andrea F. Wainer

Independent Director

6.09K

--

Mr. Thierry Bernard

Independent Director

5.62K

--

名称

名称/职务

职务

持股

持股变动

Mr. John Edward Adent

President, Chief Executive Officer, Director

271.28K

+0.78%

Mr. David Hartman Naemura

Chief Financial Officer, Chief Operating Officer

124.19K

+73.77%

Mr. James C. (Jim) Borel

Independent Chairman of the Board

90.47K

+255.16%

Dr. Amy M. Rocklin, Ph.D.

Chief Legal & Compliance Officer

80.44K

+118.27%

Dr. William T. (Bill) Boehm, Ph.D.

Independent Director

35.59K

+16.34%

Ms. Aashima Gupta

Independent Director

27.99K

+133.42%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Culture Media & Other

77.74M

35.18%

Bacterial & General Sanitation

39.88M

18.05%

Rodenticides, Insecticides & Disinfectants

35.64M

16.13%

Genomics Services

22.70M

10.27%

Natural Toxins, Allergens & Drug Residues

17.59M

7.96%

Other

27.41M

12.41%

地区USD

名称

营收

占比

Domestic

115.36M

52.21%

International

105.61M

47.79%

业务

地区

业务USD

名称

营收

占比

Culture Media & Other

77.74M

35.18%

Bacterial & General Sanitation

39.88M

18.05%

Rodenticides, Insecticides & Disinfectants

35.64M

16.13%

Genomics Services

22.70M

10.27%

Natural Toxins, Allergens & Drug Residues

17.59M

7.96%

Other

27.41M

12.41%

股东统计

更新时间: 22 小时前

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.19%

The Vanguard Group, Inc.

10.83%

William Blair Investment Management, LLC

4.33%

Baillie Gifford & Co.

4.22%

Gates Capital Management, Inc.

4.22%

Other

63.21%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.19%

The Vanguard Group, Inc.

10.83%

William Blair Investment Management, LLC

4.33%

Baillie Gifford & Co.

4.22%

Gates Capital Management, Inc.

4.22%

Other

63.21%

股东类型

持股股东

占比

Investment Advisor

64.46%

Investment Advisor/Hedge Fund

43.57%

Hedge Fund

6.03%

Sovereign Wealth Fund

4.26%

Research Firm

3.39%

Pension Fund

1.74%

Bank and Trust

1.03%

Individual Investor

0.41%

Private Equity

0.31%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

712

280.17M

129.09%

-8.82M

2025Q1

753

280.62M

129.30%

-9.42M

2024Q4

764

265.86M

122.55%

-15.84M

2024Q3

778

258.29M

119.19%

-21.39M

2024Q2

791

255.45M

117.89%

-8.15M

2024Q1

783

241.86M

111.66%

-5.94M

2023Q4

783

234.38M

108.27%

-1.28M

2023Q3

770

225.33M

104.20%

-18.20M

2023Q2

761

232.20M

107.41%

-2.78M

2023Q1

759

225.00M

104.19%

-1.65M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

28.62M

13.19%

+5.44M

+23.46%

Mar 31, 2025

The Vanguard Group, Inc.

23.51M

10.83%

+1.91M

+8.86%

Mar 31, 2025

William Blair Investment Management, LLC

13.56M

6.25%

-787.83K

-5.49%

Mar 31, 2025

Baillie Gifford & Co.

9.16M

4.22%

-590.13K

-6.05%

Mar 31, 2025

Gates Capital Management, Inc.

9.16M

4.22%

+9.16M

--

Mar 31, 2025

Norges Bank Investment Management (NBIM)

14.81M

6.82%

-2.67M

-15.27%

Mar 31, 2025

State Street Global Advisors (US)

8.61M

3.97%

+282.73K

+3.40%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

8.46M

3.9%

+1.34M

+18.89%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

8.44M

3.89%

+1.50M

+21.56%

Mar 31, 2025

Mackenzie Investments

7.76M

3.57%

-67.86K

-0.87%

Mar 31, 2025

持股ETF

更新时间: 7月6日周日

机构名称

占比

SPDR S&P Health Care Equipment ETF

1.51%

Invesco S&P SmallCap Health Care ETF

0.83%

iShares Emergent Food and AgTech Multisector ETF

0.62%

Federated Hermes MDT Small Cap Core ETF

0.28%

VanEck Agribusiness ETF

0.26%

WisdomTree US SmallCap Quality Growth Fund

0.22%

Invesco S&P SmallCap 600 Pure Value ETF

0.22%

Amplify Etho Climate Leadership U.S. ETF

0.22%

First Trust Multi-Manager Small Cap Opportunities ETF

0.18%

ProShares MSCI Transformational Changes ETF

0.17%

SPDR S&P Health Care Equipment ETF

占比1.51%

Invesco S&P SmallCap Health Care ETF

占比0.83%

iShares Emergent Food and AgTech Multisector ETF

占比0.62%

Federated Hermes MDT Small Cap Core ETF

占比0.28%

VanEck Agribusiness ETF

占比0.26%

WisdomTree US SmallCap Quality Growth Fund

占比0.22%

Invesco S&P SmallCap 600 Pure Value ETF

占比0.22%

Amplify Etho Climate Leadership U.S. ETF

占比0.22%

First Trust Multi-Manager Small Cap Opportunities ETF

占比0.18%

ProShares MSCI Transformational Changes ETF

占比0.17%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

May 12, 2021

Split

1>2

公告日期

类型

比率

May 12, 2021

Split

1>2

Neogen Corp

4.650USD

Neogen Corp

4.650

概览

公司

财务